In collaboration with our partner TRICALS, we presented the webinar:
Efficient Patient Identification in ALS Clinical Trials; Leveraging the Concept of Fast and Slow Progressors.
During this webinar Prof. Dr. L.H. van den Berg and Dr. R.P.A. van Eijk (UMC Utrecht, the Netherlands) talked about disease heterogeneity and the use of prediction-based patient selection in ALS clinical trials.
Other subjects that were adressed:
> Prediction-based inclusion criteria
> Defining the concept of fast vs slow progressors
> Addressing disease heterogeneity and reduce variance
> Regulatory perspective (EMA) on prediction-based patient selection
Wacth the replay now.
(webinar starts at 6:56)